These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32588087)

  • 21. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
    Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
    Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of exposure to perfluoroalkyl substances with serum uric acid change and hyperuricemia among Chinese women: Results from a longitudinal study.
    Feng Y; Fu M; Guan X; Wang C; Meng H; Zhou Y; He M; Guo H
    Chemosphere; 2022 Dec; 308(Pt 3):136438. PubMed ID: 36116625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs.
    Foguth RM; Flynn RW; de Perre C; Iacchetta M; Lee LS; Sepúlveda MS; Cannon JR
    Toxicol Appl Pharmacol; 2019 Aug; 377():114623. PubMed ID: 31195004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.
    Wolf CJ; Rider CV; Lau C; Abbott BD
    Toxicology; 2014 Feb; 316():43-54. PubMed ID: 24374136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.
    Beggs KM; McGreal SR; McCarthy A; Gunewardena S; Lampe JN; Lau C; Apte U
    Toxicol Appl Pharmacol; 2016 Aug; 304():18-29. PubMed ID: 27153767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells.
    Shan G; Ye M; Zhu B; Zhu L
    Chemosphere; 2013 Nov; 93(9):2101-7. PubMed ID: 23972907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of exposure to multiple perfluoroalkyl and polyfluoroalkyl substances and glucose metabolism in National Health and Nutrition Examination Survey 2017-2018.
    Tian Q; Yang Y; An Q; Li Y; Wang Q; Zhang P; Zhang Y; Zhang Y; Mu L; Lei L
    Front Public Health; 2024; 12():1370971. PubMed ID: 38633237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HNF4A as a potential target of PFOA and PFOS leading to hepatic steatosis: Integrated molecular docking, molecular dynamic and transcriptomic analyses.
    Li R; Zhang Z; Xuan Y; Wang Y; Zhong Y; Zhang L; Zhang J; Chen Q; Yu S; Yuan J
    Chem Biol Interact; 2024 Feb; 390():110867. PubMed ID: 38199259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using 2003-2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications.
    Dong Z; Wang H; Yu YY; Li YB; Naidu R; Liu Y
    Ecotoxicol Environ Saf; 2019 May; 173():461-468. PubMed ID: 30798190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal exposure to perfluoroalkyl chemicals and anogenital distance in the offspring: A Faroese cohort study.
    Christensen JVR; Bangash KK; Weihe P; Grandjean P; Nielsen F; Jensen TK; Petersen MS
    Reprod Toxicol; 2021 Sep; 104():52-57. PubMed ID: 34182087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association between Multiple Per- and Polyfluoroalkyl Substances' Serum Levels and Allostatic Load.
    Bashir T; Obeng-Gyasi E
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
    Fragki S; Dirven H; Fletcher T; Grasl-Kraupp B; Bjerve Gützkow K; Hoogenboom R; Kersten S; Lindeman B; Louisse J; Peijnenburg A; Piersma AH; Princen HMG; Uhl M; Westerhout J; Zeilmaker MJ; Luijten M
    Crit Rev Toxicol; 2021 Feb; 51(2):141-164. PubMed ID: 33853480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental toxicity of perfluorononanoic acid in mice.
    Das KP; Grey BE; Rosen MB; Wood CR; Tatum-Gibbs KR; Zehr RD; Strynar MJ; Lindstrom AB; Lau C
    Reprod Toxicol; 2015 Jan; 51():133-44. PubMed ID: 25543169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.
    Schlezinger JJ; Hyötyläinen T; Sinioja T; Boston C; Puckett H; Oliver J; Heiger-Bernays W; Webster TF
    Toxicol Appl Pharmacol; 2021 Sep; 426():115644. PubMed ID: 34252412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The degradation mechanisms of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) by different chemical methods: A critical review.
    Deng Y; Liang Z; Lu X; Chen D; Li Z; Wang F
    Chemosphere; 2021 Nov; 283():131168. PubMed ID: 34182635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.